Subscribe to Newsletter

Content by Luke Turner:

Inside the Lab Digital and computational pathology

A Real PAIGE-Turner

| Luke Turner

Paige.AI is developing deep learning algorithms to revolutionize cancer diagnostics

Diagnostics Analytical science

Unraveling the D-Amino Acid Mystery

| Luke Turner

D-serine has shown potential as a biomarker for the prediction of kidney function and the detection of chronic kidney disease

Diagnostics Microbiology and immunology

Out With the Old

| Luke Turner

Existing tests for rapid diagnosis of TB are costly and insufficient – but second-generation assays with improved sensitivity could be the answer

Diagnostics Digital and computational pathology

Biosensors for the Future

| Luke Turner

From a new material for lung cancer diagnosis to real-time robotics for monitoring reproductive hormones, discover our latest bite-sized breakthroughs

Diagnostics Analytical science

Biomarkers Beyond Our Wildest Dreams

| Luke Turner

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease

Subspecialties Biochemistry and molecular biology

Jagged Little Pill (for Cancer)

| Luke Turner

A Jagged protein directly linked to cancer metastasis could be targeted to assess the aggressiveness of tumors and prevent their rapid spread

Outside the Lab Genetics and epigenetics

From Sports Captain to Genome Mapper

| Luke Turner

We sit down with England’s Chief Scientific Officer, Professor Dame Sue Hill, to learn how genomics will influence the future of pathology.

Inside the Lab Biochemistry and molecular biology

A Fluid Future

| Luke Turner

Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?

Diagnostics Liquid biopsy

A Diagnostic to Drool Over?

| Luke Turner

The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid

Subspecialties Microbiology and immunology

Monitoring the Microbiome

| Luke Turner

Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register